MEDIRESEARCH: what changed
What changed
MEDIRESEARCH
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Net result for the year
€180,357
2024 · €133,146+€47,211
Equity
€285,931
2024 · €590,574-€304,643
Cash
€529,912
2024 · €59,590+€470,322
Balance sheet total
€798,885
2024 · €690,650+€108,235
Largest movements
Assets
- Cash +€470,322
up €470,322 (+789%), from €59,590 to €529,912
mainly Other debts (+€408,223) and Current investments (+€345,000)
- Current investments -€345,000
down €345,000 (-57.5%), from €600,000 to €255,000
- Receivables within one year -€10,130
down €10,130 (-57.5%), from €17,615 to €7,486
Equity and liabilities
- Other debts +€408,223
up €408,223 (+517%), from €79,001 to €487,224
- Reserves -€305,000
down €305,000 (-54.0%), from €564,860 to €259,860
Income statement
- Gross operating margin +€60,061
up €60,061 (+25.7%), from €233,566 to €293,627
- Financial income -€8,392
down €8,392 (-90.4%), from €9,280 to €888
- Taxes +€8,273
up €8,273 (+14.4%), from €57,271 to €65,544
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€133,146
Gross operating margin
+€60,061
Staff costs
+€2,929
Depreciation
+€559
Other operating charges
+€417
Financial income
-€8,392
Financial charges
-€90
Taxes
-€8,273
Result 2025
€180,357
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€610,322
Investment
+€345,000
Financing
-€485,000
Cash 2024
€59,590
From operations (derived)
+€610,322
Net result for the year
+€180,357
Depreciation
+€2,167
Receivables within one year
+€10,130
Deferred charges and accrued income
+€4,790
Trade debts
-€1,885
Tax, wage and social debts
+€6,540
Other debts
+€408,223
Investment (derived)
+€345,000
Current investments
+€345,000
Financing
-€485,000
Contributions, distributions and other
-€485,000
Cash 2025
€529,912
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €690,650 | €798,885 | +€108,235 | +15.7% |
| Fixed assets | 21/28 | €3,690 | €1,523 | -€2,167 | -58.7% |
| Intangible fixed assets | 21 | €1,073 | €533 | -€540 | -50.3% |
| Tangible fixed assets | 22/27 | €2,617 | €990 | -€1,627 | -62.2% |
| Plant, machinery and equipment | 23 | €2,310 | €990 | -€1,321 | -57.2% |
| Furniture and vehicles | 24 | €307 | €0 | -€307 | -100% |
| Current assets | 29/58 | €686,959 | €797,362 | +€110,402 | +16.1% |
| Amounts receivable after more than one year | 29 | €0 | - | = | |
| Other amounts receivable | 291 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €17,615 | €7,486 | -€10,130 | -57.5% |
| Other amounts receivable | 41 | €17,615 | €7,486 | -€10,130 | -57.5% |
| Current investments | 50/53 | €600,000 | €255,000 | -€345,000 | -57.5% |
| Cash at bank and in hand | 54/58 | €59,590 | €529,912 | +€470,322 | +789% |
| Deferred charges and accrued income | 490/1 | €9,754 | €4,964 | -€4,790 | -49.1% |
| Total equity and liabilities | 10/49 | €690,650 | €798,885 | +€108,235 | +15.7% |
| Equity | 10/15 | €590,574 | €285,931 | -€304,643 | -51.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €564,860 | €259,860 | -€305,000 | -54.0% |
| Distributable reserves | 133 | €564,860 | €259,860 | -€305,000 | -54.0% |
| Profit (loss) carried forward | 14 | €7,114 | €7,471 | +€357 | +5.0% |
| Amounts payable | 17/49 | €100,075 | €512,953 | +€412,878 | +413% |
| Amounts payable within one year | 42/48 | €100,075 | €512,953 | +€412,878 | +413% |
| Trade debts | 44 | €2,071 | €186 | -€1,885 | -91.0% |
| Suppliers | 440/4 | €2,071 | €186 | -€1,885 | -91.0% |
| Taxes, remuneration and social security | 45 | €19,003 | €25,543 | +€6,540 | +34.4% |
| Taxes | 450/3 | €13,634 | €19,847 | +€6,212 | +45.6% |
| Remuneration and social security | 454/9 | €5,369 | €5,697 | +€328 | +6.1% |
| Other amounts payable | 47/48 | €79,001 | €487,224 | +€408,223 | +517% |
| Remuneration, social security and pensions | 62 | €46,605 | €43,676 | -€2,929 | -6.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,726 | €2,167 | -€559 | -20.5% |
| Other operating charges | 640/8 | €1,851 | €1,434 | -€417 | -22.5% |
| Gross operating margin | 9900 | €233,566 | €293,627 | +€60,061 | +25.7% |
| Operating profit (loss) | 9901 | €182,384 | €246,350 | +€63,966 | +35.1% |
| Financial income | 75/76B | €9,280 | €888 | -€8,392 | -90.4% |
| Recurring financial income | 75 | €9,280 | €888 | -€8,392 | -90.4% |
| Financial charges | 65/66B | €1,247 | €1,337 | +€90 | +7.3% |
| Recurring financial charges | 65 | €1,247 | €1,337 | +€90 | +7.3% |
| Profit (loss) for the period before taxes | 9903 | €190,417 | €245,901 | +€55,484 | +29.1% |
| Income taxes | 67/77 | €57,271 | €65,544 | +€8,273 | +14.4% |
| Profit (loss) for the period | 9904 | €133,146 | €180,357 | +€47,211 | +35.5% |
| Profit (loss) for the period to be appropriated | 9905 | €133,146 | €180,357 | +€47,211 | +35.5% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.